Discover

LSTA
Lisata Therapeutics, Inc.
2.18
1 x 2.16
5 x 2.20
bid
ask
-
0.06
2.68%
11:58 AM
timesize
Ytd17.20%
1y-17.42%
2.12
day range
2.20
1.81
52 week range
5.07
Open2.12Prev Close2.24Low2.12High2.20Mkt Cap20.40M
Vol45.02KAvg Vol108.02KEPS-1.86P/E-1.20Forward P/E-1.20
Beta0.79Short Ratio1.79Inst. Own9.07%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg3.35200-d Avg3.301yr Est14.00
Income Statement
Operating Expenses4.94M
Research and Development Expense1.20M
Selling, General and Administrative Expense3.74M
Operating Income-4.94M
Income Tax Expense-387.00K
Net Income-4.49M
Net Income Common Stock-4.49M
Net Income Common Stock (USD)-4.49M
Consolidated Income-4.49M
Earnings per Basic Share-0.50
Earnings per Basic Share (USD)-0.50
Earnings per Diluted Share-0.50
Earning Before Interest & Taxes (EBIT)-4.88M
Earning Before Interest & Taxes (USD)-4.88M
Weighted Average Shares9.01M
Weighted Average Shares Diluted9.01M
Balance Sheet
Cash and Equivalents13.06M
Cash and Equivalents (USD)13.06M
Current Assets14.02M
Property, Plant & Equipment Net16.00K
Total Assets14.06M
Current Liabilities3.32M
Total Liabilities3.39M
Accumulated Retained Earnings (Deficit)-569.14M
Accumulated Other Comprehensive Income-21.00K
Shareholders Equity10.93M
Shareholders Equity (USD)10.93M
Assets Non-Current39.00K
Liabilities Non-Current72.00K
Trade and Non-Trade Payables510.00K
Cash Flow
Depreciation, Amortization & Accretion2.00K
Net Cash Flow from Financing181.00K
Net Cash Flow / Change in Cash & Cash Equivalents-2.90M
Issuance (Purchase) of Equity Shares340.00K
Net Cash Flow from Operations-3.08M
Effect of Exchange Rate Changes on Cash 6.00K
Share Based Compensation364.00K